These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6865806)

  • 1. Fecal excretion associated with Ca2+ dependency of Yersinia enterocolitica O3 and O9 and Yersinia pseudotuberculosis in mice.
    Kaneko K; Hashimoto N
    Microbiol Immunol; 1983; 27(2):199-202. PubMed ID: 6865806
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-resistance to fecal excretion of Yersinia enterocolitica in mice by oral vaccination of killed cells.
    Kaneko K; Hashimoto N
    Infect Immun; 1983 Jun; 40(3):1223-5. PubMed ID: 6852921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term fecal excretion and resistance induced in mice infected with Yersinia enterocolitica.
    Ricciardi ID; Pearson AD; Suckling WG; Klein C
    Infect Immun; 1978 Jul; 21(1):342-4. PubMed ID: 711321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological study of Yersinia enterocolitica and Yersinia pseudotuberculosis infections in Shimane Prefecture, Japan.
    Fukushima H; Tsubokura M; Otsuki K; Kawaoka Y; Nishio R; Moriki S; Nishino Y; Mototsune H; Karino K
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 May; 180(5-6):515-27. PubMed ID: 3895776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection against fecal excretion of Yersinia enterocolitica and Yersinia pseudotuberculosis in mice by oral vaccination of viable cells.
    Uchida I; Kaneko K; Hashimoto N
    Infect Immun; 1982 May; 36(2):837-40. PubMed ID: 6177641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of human infection with Yersinia enterocolitica serotypes O3, O8, and O9 and the use of indirect immunofluorescence in diagnosis.
    Hoogkamp-Korstanje JA; de Koning J; Samsom JP
    J Infect Dis; 1986 Jan; 153(1):138-41. PubMed ID: 3510258
    [No Abstract]   [Full Text] [Related]  

  • 7. [Initial isolation and characterization of Yersinia enterocolitica in human feces in Argentina].
    Eiguer T; Mercado EC; Fronchkowsky B; Foguelman A; Fernández E; Marguet R; Pratalongo JP; Urbano FF; Ibáñez SB; Ruiz Trevisan A
    Rev Argent Microbiol; 1987; 19(2):71-6. PubMed ID: 3503312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly specific one-step PCR - assay for the rapid discrimination of enteropathogenic Yersinia enterocolitica from pathogenic Yersinia pseudotuberculosis and Yersinia pestis.
    Arnold T; Hensel A; Hagen R; Aleksic S; Neubauer H; Scholz HC
    Syst Appl Microbiol; 2001 Jul; 24(2):285-9. PubMed ID: 11518333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Chart H; Cheasty T
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the keratoconjunctival test for determining the virulence of the causative agent of pseudotuberculosis].
    Polotskiĭ IuE; Tseneva GIa; Efremov VE; Kleganov VK
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):72-6. PubMed ID: 6346760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial outbreak of Yersinia enterocolitica serotype O9 biotype 2.
    Moriki S; Nobata A; Shibata H; Nagai A; Minami N; Taketani T; Fukushima H
    J Infect Chemother; 2010 Feb; 16(1):56-8. PubMed ID: 20072799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal immunoglobulin A (IgA) antibodies to Yersinia enterocolitica in mice orally vaccinated and infected.
    Shimono K; Kaneko K; Hayashidani H; Ogawa M
    Nihon Juigaku Zasshi; 1989 Apr; 51(2):273-7. PubMed ID: 2739202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of PCR fingerprinting to the differentiation of Yersinia enterocolitica strains isolated from humans and pigs.
    Kot B; Błaszczyk M
    Acta Microbiol Pol; 2003; 52(4):355-9. PubMed ID: 15095922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica.
    Robins-Browne RM; Prpic JK
    Infect Immun; 1985 Mar; 47(3):774-9. PubMed ID: 3972453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of faecal shedding of Yersinia enterocolitica and Yersinia pseudotuberculosis by Merino lambs in south-eastern Australia.
    Stanger KJ; McGregor H; Marenda M; Morton JM; Larsen JWA
    Prev Vet Med; 2018 May; 153():30-41. PubMed ID: 29653732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersiniosis in France: overview and potential sources of infection.
    Le Guern AS; Martin L; Savin C; Carniel E
    Int J Infect Dis; 2016 May; 46():1-7. PubMed ID: 26987478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Yersinia enterocolitica in fecal cultures: 5 years' experience].
    López-Brea M; Collado L; de Rafael L; Baquero M
    Rev Sanid Hig Publica (Madr); 1984; 58(5-6):481-7. PubMed ID: 6531627
    [No Abstract]   [Full Text] [Related]  

  • 18. Serobacteriological investigation on the animal reservoir of human Yersinia enterocolitica O3 and O9 serotypes.
    Rusu V; Ciocâlteu L; Muscan A; Lăzăroae D
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):25-31. PubMed ID: 7185345
    [No Abstract]   [Full Text] [Related]  

  • 19. A new quantitative method for oral vaccination of killed cells and persistence of the vaccination against fecal excretion of Yersinia enterocolitica.
    Yanagisawa J; Kaneko K; Hayashidani H; Ogawa M
    Nihon Juigaku Zasshi; 1987 Oct; 49(5):795-9. PubMed ID: 3682519
    [No Abstract]   [Full Text] [Related]  

  • 20. Yersinia enterocolitica plasmid in fecal flora of patients with reactive arthritis.
    Viitanen AM; Pulkkinen L; Lahesmaa-Rantala R; Huovinen P; Toivanen A
    J Infect Dis; 1986 Aug; 154(2):376. PubMed ID: 3722874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.